6020 related articles for article (PubMed ID: 2405066)
41. Isolation and characterization of a heterodimeric surface antigen on human melanoma cells and evidence that it is the 4F2 cell activation/proliferation molecule.
Dixon WT; Sikora LK; Demetrick DJ; Jerry LM
Int J Cancer; 1990 Jan; 45(1):59-68. PubMed ID: 2404879
[TBL] [Abstract][Full Text] [Related]
42. Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets.
Metzelaar MJ; Korteweg J; Sixma JJ; Nieuwenhuis HK
Thromb Haemost; 1991 Dec; 66(6):700-7. PubMed ID: 1796415
[TBL] [Abstract][Full Text] [Related]
43. Biosynthesis, glycosylation and intracellular processing of the neuroglandular antigen, a human melanoma-associated antigen.
Dixon WT; Demetrick DJ; Ohyama K; Sikora LK; Jerry LM
Cancer Res; 1990 Aug; 50(15):4557-65. PubMed ID: 2369731
[TBL] [Abstract][Full Text] [Related]
44. Further analyses of epitopes for human monoclonal anti-basement membrane zone antibodies produced by stable human hybridoma cell lines constructed with Epstein-Barr virus transformants.
Hashimoto T; Amagai M; Ebihara T; Gamou S; Shimizu N; Tsubata T; Hasegawa A; Miki K; Nishikawa T
J Invest Dermatol; 1993 Mar; 100(3):310-5. PubMed ID: 7680057
[TBL] [Abstract][Full Text] [Related]
45. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.
Wilson BS; Imai K; Natali PG; Ferrone S
Int J Cancer; 1981 Sep; 28(3):293-300. PubMed ID: 7033148
[TBL] [Abstract][Full Text] [Related]
46. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
47. Phenotypic diversity of murine B16 melanoma detected by anti-B16 monoclonal antibodies.
Johnson CW; Barth RF; Adams D; Holman B; Price JE; Sautins I
Cancer Res; 1987 Feb; 47(4):1111-7. PubMed ID: 2433032
[TBL] [Abstract][Full Text] [Related]
48. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA.
Adema GJ; de Boer AJ; van 't Hullenaar R; Denijn M; Ruiter DJ; Vogel AM; Figdor CG
Am J Pathol; 1993 Dec; 143(6):1579-85. PubMed ID: 7504884
[TBL] [Abstract][Full Text] [Related]
49. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
Kantor RR; Ng AK; Giacomini P; Ferrone S
Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
[TBL] [Abstract][Full Text] [Related]
50. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
Salgar SK; Paape MJ; Alston-Mills B
Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
[TBL] [Abstract][Full Text] [Related]
51. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ
J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165
[TBL] [Abstract][Full Text] [Related]
52. Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody.
Vogel AM; Esclamado RM
Cancer Res; 1988 Mar; 48(5):1286-94. PubMed ID: 3342407
[TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibodies against human breast tumor-associated antigens: characterization of B21 antigen.
Annibali NV; San Martino JA; Baldi A
J Natl Cancer Inst; 1994 Feb; 86(3):215-21. PubMed ID: 8283494
[TBL] [Abstract][Full Text] [Related]
54. A melanosome-associated monoclonal antibody J1 recognizes luminal membrane of prelysosomes common to biogenesis of melanosomes and lysosomes.
Shinoda K; Wada I; Jin HY; Jimbow K
Cell Struct Funct; 2001 Jun; 26(3):169-77. PubMed ID: 11565809
[TBL] [Abstract][Full Text] [Related]
55. Analysis of a glycoprotein of human herpesvirus 6 (HHV-6) using monoclonal antibodies.
Okuno T; Sao H; Asada H; Shiraki K; Takahashi M; Yamanishi K
Virology; 1990 Jun; 176(2):625-8. PubMed ID: 2161152
[TBL] [Abstract][Full Text] [Related]
56. Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture.
Herlyn M; Rodeck U; Mancianti M; Cardillo FM; Lang A; Ross AH; Jambrosic J; Koprowski H
Cancer Res; 1987 Jun; 47(12):3057-61. PubMed ID: 3034401
[TBL] [Abstract][Full Text] [Related]
57. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1.
Kawakami Y; Battles JK; Kobayashi T; Ennis W; Wang X; Tupesis JP; Marincola FM; Robbins PF; Hearing VJ; Gonda MA; Rosenberg SA
J Immunol Methods; 1997 Mar; 202(1):13-25. PubMed ID: 9075767
[TBL] [Abstract][Full Text] [Related]
58. Monoclonal antibodies to various morphologic components of human skin.
Aiba S; Masuko T; Hosokawa M; Hashimoto Y
J Invest Dermatol; 1983 Dec; 81(6):498-502. PubMed ID: 6196419
[TBL] [Abstract][Full Text] [Related]
59. Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens.
Fukaya T; Hashimoto K; Eto H; Mehregan A
Cancer Res; 1986 Oct; 46(10):5195-200. PubMed ID: 3756874
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of tumor cell growth in vitro by murine monoclonal antibodies that recognize a proliferation-associated cell surface antigen system in rats and humans.
Yagita H; Masuko T; Hashimoto Y
Cancer Res; 1986 Mar; 46(3):1478-84. PubMed ID: 2417704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]